Cost-effectiveness of Treatment for Acute Childhood Idiopathic Thrombocytopenic Purpura (ITP) – a Systematic Review

Author： Chen M   Zhang L-L   Hu M   Gao J   Tong R-S  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.36, Iss.3, 2008-05, pp. : 572-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

Eltrombopag is an effective treatment for patients with chronic idiopathic thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

By Imbach P.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 795-801

Adis International

Access to resources Recommend Favorite

Novel Thrombopoietic Agents: A Review of Their Use in Idiopathic Thrombocytopenic Purpura

By Stasi Roberto  

Drugs, Vol. 68, Iss. 7, 2008-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Treatment Options in Patients with Alzheimer's Disease: A Systematic Review of Cost-Effectiveness Analyses

By Pouryamout Laura  

Drugs, Vol. 72, Iss. 6, 2012-04 ,pp. : 789-802

Adis International

Access to resources Recommend Favorite